Cardiff Lexington Corporation asset turnover ratio, the ability of Cardiff Lexington Corporation's assets to generate revenue in the forth quarter 2024, increased sequentially to
0.35 in the fourth quarter (Dec 31 2024), yet the ratio remained below the average, as CDIF's position remain challenging.
Within
sector 34 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Forth Quarter 2024 compared to the preceding quarter from
1665 to
2396.
Asset Turnover Ratio Definition
| Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector | Asset Turnover Ratio | Revenues for 12 Months ending Dec 31 2024 | Assets at quarter ending Dec 31 2024 |
| Accuray Incorporated | 0.95 | $ 445.029 Millions | $ 470.654 Millions |
| Healthlynked Corp | 0.95 | $ 3.008 Millions | $ 3.183 Millions |
| Ensign Group Inc | 0.94 | $ 4,260.485 Millions | $ 4,511.066 Millions |
| Cerus Corporation | 0.94 | $ 179.522 Millions | $ 191.272 Millions |
| Biocryst Pharmaceuticals Inc | 0.94 | $ 450.712 Millions | $ 480.496 Millions |
| Angiodynamics Inc | 0.93 | $ 286.006 Millions | $ 306.923 Millions |
| Treace Medical Concepts Inc | 0.93 | $ 209.357 Millions | $ 224.707 Millions |
| Cytomx Therapeutics Inc | 0.92 | $ 138.103 Millions | $ 150.855 Millions |
| Ensysce Biosciences Inc | 0.91 | $ 5.210 Millions | $ 5.713 Millions |
| National Healthcare Corp | 0.91 | $ 1,307.382 Millions | $ 1,436.619 Millions |
| Select Medical Holdings Corp | 0.90 | $ 6,622.256 Millions | $ 7,336.044 Millions |
| Corcept Therapeutics Inc | 0.90 | $ 675.040 Millions | $ 748.825 Millions |
| Orthofix Medical Inc | 0.90 | $ 798.885 Millions | $ 887.304 Millions |
| Ardelyx Inc | 0.90 | $ 333.615 Millions | $ 372.372 Millions |
| Ironwood Pharmaceuticals inc | 0.89 | $ 351.410 Millions | $ 393.717 Millions |
| Community Health Systems Inc | 0.89 | $ 12,634.000 Millions | $ 14,196.750 Millions |
| Apellis Pharmaceuticals Inc | 0.89 | $ 781.367 Millions | $ 880.832 Millions |
| Strata Skin Sciences Inc | 0.88 | $ 34.749 Millions | $ 39.451 Millions |
| Eton Pharmaceuticals Inc | 0.88 | $ 38.411 Millions | $ 43.645 Millions |
| National Vision Holdings Inc | 0.88 | $ 1,823.320 Millions | $ 2,082.392 Millions |
| Airsculpt Technologies Inc | 0.87 | $ 180.350 Millions | $ 207.766 Millions |
| Gyre Therapeutics Inc | 0.86 | $ 105.757 Millions | $ 123.396 Millions |
| Encompass Health Corporation | 0.84 | $ 5,373.200 Millions | $ 6,403.300 Millions |
| Bionexus Gene Lab Corp | 0.84 | $ 9.230 Millions | $ 11.034 Millions |
| Lensar Inc | 0.84 | $ 53.494 Millions | $ 63.964 Millions |
| Paragon 28 inc | 0.83 | $ 255.489 Millions | $ 306.890 Millions |
| Delcath Systems Inc | 0.83 | $ 37.017 Millions | $ 44.571 Millions |
| Neuropace Inc | 0.82 | $ 79.085 Millions | $ 96.048 Millions |
| Msa Safety Incorporated | 0.82 | $ 1,807.445 Millions | $ 2,216.403 Millions |
| Journey Medical Corp | 0.81 | $ 56.134 Millions | $ 69.011 Millions |
